Angiotensin AT2 receptor degradation is prevented by ligand occupation

Biochemical and Biophysical Research Communications

Volumn 243, Issue 1, 1998, Pages 142-147

  Csikós, Tamás ^a   Balmforth, Anthony J ^b   Grojec, Monika ^a   Gohlke, Peter ^a   Culman, Juraj ^a   Unger, Thomas ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; RADIOLIGAND; ACID; ANGIOTENSIN II; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; ANGIOTENSIN RECEPTOR; GLYCINE; LIGAND; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL STRAIN 3T3; CELL SURFACE; KIDNEY CELL; LIGAND BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TIME; ANIMAL; CELL LINE; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; METABOLISM; RADIOASSAY;

ANIMALIA;

1-SARCOSINE-8-ISOLEUCINE ANGIOTENSIN II; 3T3 CELLS; ACIDS; ANGIOTENSIN II; ANIMALS; CELL LINE; GLYCINE; HUMANS; LIGANDS; MICE; RADIOLIGAND ASSAY; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RECOMBINANT PROTEINS;

EID: 0032481170     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.8042     Document Type: Article

References (20)

1. Timmermans P. B. M. W. M., Wong P. C., Chiu A. T., Herblin W. F., Benfield P., Carini D. J., Lee R. J., Wexler R. R., Saye J. A. M., Smith R. D. Pharmacol. Rev. 45:1993;205-251.
2. Unger Th., Chung O., Csikós T., Culman J., Gallinat S., Gohlke P., Höhle S., Meffert S., Stoll M., Stroth U., Zhu Y. Z. J. Hypertens. 14:1996;S95-S103.
3. Stoll M., Steckelings U. M., Paul M., Bottari S. P., Metzger R., Unger Th. J. Clin. Invest. 95:1995;651-657.
4. van Kesteren C. A. M., van Heugten H. A. A., Lamers J. M. J., Saxena P. R., Schalekamp M. A. D. H., Danser A. H. J. J. Mol. Cell. Cardiol. 29:1997;2147-2157.
5. Yamada T., Horiuchi M., Dzau V. J. Proc. Natl. Acad. Sci. 93:1996;156-160.
6. Horiuchi M., Hayashida W., Kambe T., Yamada T., Dzau V. J. J. Biol. Chem. 272:1997;19022-19026.
7. Tanaka M., Ohnishi J., Ozawa Y., Sugimoto M., Usuki S., Naruse M., Murakami K., Miyazaki H. Biochem. Biophys. Res. Comm. 207:1995;593-598.
8. Gallinat S., Csikós T., Meffert S., Herdegen T., Stoll M., Unger Th. Neuro. Lett. 227:1997;29-32.
9. Meffert S., Stoll M., Steckelings U. M., Bottari S. P., Unger Th. Moll. Cell. Endocrinol. 122:1996;59-67.
10. Laflamme L., de Gasparo M., Gallo J. M., Payet M. D., Gallo-Payet N. J. Biol. Chem. 271:1996;22729-22735.
11. Grady E. F., Sechi L. A., Griffin C. A., Schambelan M., Kalinyak J. E. J. Clin. Invest. 88:1991;921-933.
12. Dudley D. T., Summerfelt R. M. Reg. Pep. 44:1993;199-206.
13. Dudley D. T., Hubbell S. E., Summerfelt R. M. Mol. Pharmacol. 40:1991;360-367.
14. Camp H. S., Dudley D. T. Receptor. 5:1995;123-132.
15. Ichiki T., Kambayashi Y., Inagami T. Circ. Res. 77:1995;1070-1076.
16. de Gasparo M., Whitebread S., Mele M., Motani A. S., Whitcombe P. J., Ramjoue H. P., Kamber B. J. Cardiovasc. Pharmacol. 16:1990;S31-35.
17. Whitebread S., Mele M., Kamber B., de Gasparo M. Biochem. Biophys. Res. Commun. 163:1989;284-291.
18. Balmforth A. J., Lee A. J., Warburton P., Donnelly D., Ball S. G. J. Biol. Chem. 272:1997;4245-4251.
19. Hein L., Meinel L., Pratt R. E., Dzau V. J., Kobilka B. K. Mol. Endocrinol. 11:1997;1266-1277.
20. Mukoyama M., Horiuchi M., Nakajima M., Pratt R. E., Dzau V. J. Mol. Cell. Endocrinol. 112:1995;61-88.